BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 2834022)

  • 21. Breeding history of the Stanford colony of narcoleptic dogs.
    Cederberg R; Nishino S; Dement WC; Mignot E
    Vet Rec; 1998 Jan; 142(2):31-6. PubMed ID: 9481825
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sulpiride, a D2/D3 blocker, reduces cataplexy but not REM sleep in canine narcolepsy.
    Okura M; Riehl J; Mignot E; Nishino S
    Neuropsychopharmacology; 2000 Nov; 23(5):528-38. PubMed ID: 11027918
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Heart rate and blood pressure changes during sleep-waking cycles and cataplexy in narcoleptic dogs.
    Siegel JM; Tomaszewski KS; Fahringer H; Cave G; Kilduff T; Dement WC
    Am J Physiol; 1989 Jan; 256(1 Pt 2):H111-9. PubMed ID: 2912173
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification and functional analysis of mutations in the hypocretin (orexin) genes of narcoleptic canines.
    Hungs M; Fan J; Lin L; Lin X; Maki RA; Mignot E
    Genome Res; 2001 Apr; 11(4):531-9. PubMed ID: 11282968
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The relationship between density of alpha-adrenoceptor binding sites and contractile responses in several porcine isolated blood vessels.
    Wright IK; Blaylock NA; Kendall DA; Wilson VG
    Br J Pharmacol; 1995 Feb; 114(3):678-88. PubMed ID: 7735695
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Analysis of onset location, laterality and propagation of cataplexy in canine narcolepsy.
    Fujiki N; Morris L; Mignot E; Nishino S
    Psychiatry Clin Neurosci; 2002 Jun; 56(3):275-6. PubMed ID: 12047593
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Review of pathophysiology and clinical management of narcolepsy in dogs.
    Tonokura M; Fujita K; Nishino S
    Vet Rec; 2007 Sep; 161(11):375-80. PubMed ID: 17873267
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The neurobiology of narcolepsy-cataplexy syndrome.
    Aldrich MS
    Int J Neurol; 1991-1992; 25-26():29-40. PubMed ID: 11980061
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prazosin increases immobility episodes in taiep rats without changes in the properties of alpha1 receptors.
    Cortés MD; Arias-Montaño JA; Eguibar JR
    Neurosci Lett; 2007 Jan; 412(2):159-62. PubMed ID: 17194536
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of IV and ICV hypocretin-1 (orexin A) in hypocretin receptor-2 gene mutated narcoleptic dogs and IV hypocretin-1 replacement therapy in a hypocretin-ligand-deficient narcoleptic dog.
    Fujiki N; Yoshida Y; Ripley B; Mignot E; Nishino S
    Sleep; 2003 Dec; 26(8):953-9. PubMed ID: 14746374
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Neurodegenerative, autoimmune and genetic processes of human and animal narcolepsy].
    Dauvilliers Y
    Rev Neurol (Paris); 2003 Nov; 159(11 Suppl):6S83-7. PubMed ID: 14646805
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Narcolepsy.
    Foutz AS; Mitler MM; Dement WC
    Vet Clin North Am Small Anim Pract; 1980 Feb; 10(1):65-80. PubMed ID: 6996290
    [No Abstract]   [Full Text] [Related]  

  • 33. Treatment with immunosuppressive and anti-inflammatory agents delays onset of canine genetic narcolepsy and reduces symptom severity.
    Boehmer LN; Wu MF; John J; Siegel JM
    Exp Neurol; 2004 Aug; 188(2):292-9. PubMed ID: 15246829
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differential effects of prazosin on the pre- and postsynaptic alpha-adrenoceptors in the rat and dog [proceedings].
    Cavero I; Lefèvre F; Roach AG
    Br J Pharmacol; 1977 Nov; 61(3):469P. PubMed ID: 201328
    [No Abstract]   [Full Text] [Related]  

  • 35. Narcolepsy in seven dogs.
    Mitler MM; Soave O; Dement WC
    J Am Vet Med Assoc; 1976 Jun; 168(11):1036-8. PubMed ID: 945254
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Circadian distribution of rest/activity in narcoleptic and control dogs: assessment with ambulatory activity monitoring.
    Nishino S; Tafti M; Sampathkumaran R; Dement WC; Mignot E
    J Sleep Res; 1997 Jun; 6(2):120-7. PubMed ID: 9377531
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Developmental changes in CSF hypocretin-1 (orexin-A) levels in normal and genetically narcoleptic Doberman pinschers.
    John J; Wu MF; Maidment NT; Lam HA; Boehmer LN; Patton M; Siegel JM
    J Physiol; 2004 Oct; 560(Pt 2):587-92. PubMed ID: 15308685
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Narcoleptic dogs. Significance for human narcolepsy].
    Schiefer J
    Nervenarzt; 2003 Dec; 74(12):1155-6. PubMed ID: 14647919
    [No Abstract]   [Full Text] [Related]  

  • 39. Genetic studies in the sleep disorder narcolepsy.
    Kadotani H; Faraco J; Mignot E
    Genome Res; 1998 May; 8(5):427-34. PubMed ID: 9582188
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Narcolepsy without unique MHC class II antigen association: studies in the canine model.
    Dean RR; Kilduff TS; Dement WC; Grumet FC
    Hum Immunol; 1989 May; 25(1):27-35. PubMed ID: 2523880
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.